HOME//NEWS/iCamuno Biotherapeutics: Utilizing Three Platforms to Improve iPSC Differentiation EfficiencyiCamuno Biotherapeutics: Utilizing Three Platforms to Improve iPSC Differentiation Efficiency2022-08-18 09:09BACK2022.03.31Efficient Advancement of iCamuno Biotherapeutics: Completing Three Rounds of Financing in Its First Year2021.06.14Pumis and iCamuno Reach Strategic Cooperation to Develop Two Universal iPSC-CAB-NK Cell Therapy ProductsBACK
